ISA-106

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameISA-106
Drug Alias NameISA-106ISA 106
ClassificationVaccines
Mechanisms of ActionT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIsa Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesIsa Pharmaceuticals Bv
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A